tiprankstipranks
Trending News
More News >
KH Neochem Co.,Ltd. (JP:4189)
:4189
Japanese Market

KH Neochem Co.,Ltd. (4189) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4189

KH Neochem Co.,Ltd.

(4189)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
¥3,255.00
▲(31.41% Upside)
Action:ReiteratedDate:02/11/26
The score is driven primarily by solid underlying financial stability (notably conservative leverage) but tempered by mixed operating performance and historically uneven free cash flow. Technicals are supportive of an uptrend but look overextended, while valuation is a meaningful positive with a moderate P/E and strong dividend yield.
Positive Factors
Strong balance sheet
Conservative leverage (D/E ~0.26) and growing equity provide durable financial flexibility in a cyclical chemicals sector. This balance-sheet strength supports capital spending, dividend continuity and stress absorption during downturns, reducing structural refinancing and liquidity risk.
Improved cash generation (2025)
A meaningful improvement in operating and free cash flow in 2025 shows the company can convert earnings to cash at scale. Durable cash generation supports reinvestment, steady dividends and deleveraging over the medium term, improving financial resilience versus prior weak years.
Diverse product and end-market exposure
A portfolio of higher alcohols, plasticizers and intermediates sold into construction, automotive, packaging and industrial customers reduces reliance on any single market. This product and end-market diversity supports steadier demand and long-term customer relationships, tempering cycle swings.
Negative Factors
Choppy revenue trend
Range-bound top line with a recent ~6% decline signals limited secular growth visibility. For a manufacturer reliant on volume and pricing, persistent revenue volatility constrains long-term capacity planning, margin recovery and sustained reinvestment programs.
Margin normalization from cycle peak
Net margins have normalized materially from cyclical highs, indicating weaker pricing power or less operating leverage. Lower sustainable margins reduce return on capital and limit the company's ability to fund growth or buffer downturns, making earnings more sensitive to raw material swings.
Uneven free cash flow history
Volatile free-cash-flow across recent years suggests working-capital swings or lumpy capex, complicating reliable capital allocation. This inconsistency raises the risk that dividends, buybacks or investment plans could be harder to sustain through adverse cycles.

KH Neochem Co.,Ltd. (4189) vs. iShares MSCI Japan ETF (EWJ)

KH Neochem Co.,Ltd. Business Overview & Revenue Model

Company DescriptionKH Neochem Co., Ltd. researches, manufactures, and sells petrochemical products in Japan and internationally. It offers a range of chemical products, such as alcohols, esters, ketones, glycol ethers, synthetic fatty acids, aldehydes, diols, hydrocarbons, and functional monomers. The company provides basic chemicals, including butyl alcohol and acetate, 2-ethyl hexyl alcohol, and isononyl alcohol for use in paints, inks, thinners, detergents, plasticizer raw materials, and resin raw materials. It also offers performance materials, such as 2-ethyl hexanoic and isononanoic acid, diacetone acrylamide, and 1,3-butylene glycol for use in lubricants, water-borne paints, and cosmetics. In addition, the company provides electronic materials comprising propylene glycol monomethyl ether acetate–P, and propylene glycol monomethyl ether-P for LCD panels and semiconductors. KH Neochem Co., Ltd. was founded in 1966 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyKH Neochem generates revenue through the production and sale of its specialty chemical products. Its primary revenue streams include the sale of fine chemicals, which are utilized in various applications across multiple industries. The company maintains strong partnerships with key players in the pharmaceutical and electronics sectors, which contribute significantly to its earnings. Additionally, KH Neochem invests in research and development to innovate and expand its product offerings, thereby enhancing its market position and driving sales growth. The company's focus on high-quality products and customer service further solidifies its revenue generation capabilities.

KH Neochem Co.,Ltd. Financial Statement Overview

Summary
Balance sheet strength is the key positive (conservative and improving leverage; steady low-teens ROE). Offsetting this, income statement trends are mixed with a ~6% revenue decline in 2025 and margins well below the 2021 peak, while cash flow has been volatile despite a strong 2025 rebound and improved conversion.
Income Statement
62
Positive
Revenue has been broadly range-bound, with modest growth in 2024 followed by a ~6% decline in 2025, indicating a choppy demand/pricing backdrop. Profitability remains solid for the sector, with 2025 gross margin ~22% and net margin ~6.8%, but margins are well below the 2021 peak (net margin ~11.7%), pointing to a less favorable cycle and weaker operating leverage versus prior years. Overall, earnings quality looks acceptable, but the trajectory is mixed with recent top-line contraction and lower peak-to-trough profitability.
Balance Sheet
74
Positive
Leverage is conservative and improving versus earlier years: debt-to-equity is ~0.26 in 2025 (down from ~0.49 in 2020), providing balance-sheet flexibility in a cyclical chemicals environment. Equity has grown over time and returns on equity are steady in the low-teens (~11% in 2025), though below the outsized 2021 level (~25%). The main limitation is that returns have normalized, suggesting less efficient capital deployment than at the cycle peak, but overall financial risk appears well-contained.
Cash Flow
58
Neutral
Cash generation is uneven: free cash flow swung from deeply negative in 2022 and slightly negative in 2024 to strongly positive in 2023 and 2025 (about ¥9.1B in 2025). Operating cash flow improved meaningfully in 2025 (about ¥13.8B) and free cash flow covered a majority of net income (~66%), but the history of negative free cash flow in multiple years suggests working-capital and/or capital spending volatility. Net-net, current-year conversion is healthy, but consistency remains a key watch item.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue122.59B115.10B119.76B115.22B114.88B117.11B
Gross Profit26.90B24.87B25.25B21.94B24.45B32.23B
EBITDA18.72B17.32B17.00B14.46B16.01B24.19B
Net Income8.99B7.80B8.36B6.83B8.07B13.69B
Balance Sheet
Total Assets125.88B130.10B131.46B124.50B131.25B122.07B
Cash, Cash Equivalents and Short-Term Investments5.40B6.72B7.16B9.68B10.93B16.93B
Total Debt20.63B18.29B19.20B16.39B22.52B20.16B
Total Liabilities55.23B57.47B59.54B58.01B69.18B64.57B
Stockholders Equity67.80B69.68B69.09B63.74B59.35B54.92B
Cash Flow
Free Cash Flow0.009.13B-1.45B7.94B-5.36B13.00B
Operating Cash Flow0.0013.78B6.98B13.20B5.13B17.40B
Investing Cash Flow0.00-4.63B-8.90B-4.94B-10.08B-4.39B
Financing Cash Flow0.00-9.57B-645.00M-9.50B-1.08B-5.17B

KH Neochem Co.,Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2477.00
Price Trends
50DMA
2666.51
Positive
100DMA
2584.36
Positive
200DMA
2587.29
Positive
Market Momentum
MACD
123.96
Negative
RSI
74.41
Negative
STOCH
78.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4189, the sentiment is Positive. The current price of 2477 is below the 20-day moving average (MA) of 2905.65, below the 50-day MA of 2666.51, and below the 200-day MA of 2587.29, indicating a bullish trend. The MACD of 123.96 indicates Negative momentum. The RSI at 74.41 is Negative, neither overbought nor oversold. The STOCH value of 78.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4189.

KH Neochem Co.,Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥43.82B8.533.53%-3.45%30.52%
73
Outperform
¥204.68B16.434.41%3.80%-1.50%-32.46%
68
Neutral
¥868.55B25.354.79%4.21%-1.21%-27.21%
67
Neutral
¥115.56B14.283.88%2.61%30.29%
65
Neutral
¥91.59B35.930.67%10.18%-14.36%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
¥566.51B78.151.08%3.37%-1.94%-84.08%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4189
KH Neochem Co.,Ltd.
3,115.00
689.53
28.43%
JP:3405
Kuraray Co
1,845.50
16.95
0.93%
JP:4045
Toagosei Co
1,922.50
574.25
42.59%
JP:4042
Tosoh
2,729.50
740.78
37.25%
JP:4970
Toyo Gosei Co., Ltd.
11,540.00
6,408.16
124.87%
JP:5013
Yushiro Chemical Industry Co., Ltd.
3,220.00
1,250.22
63.47%

KH Neochem Co.,Ltd. Corporate Events

KH Neochem Lifts Dividends as Profitability Set to Improve Despite Flat Sales
Feb 6, 2026

KH Neochem reported a slight decline in performance for the fiscal year ended December 31, 2025, with net sales down 3.9% year on year to ¥115.1 billion and operating income falling 7.8% to ¥11.2 billion, while net income attributable to owners of the parent decreased 6.7% to ¥7.8 billion. Despite softer profits, the company maintained a solid financial position, with total assets of ¥130.1 billion, an equity ratio of 53.6%, and strong operating cash flow of ¥13.8 billion that comfortably funded investments and higher shareholder returns. The annual dividend was raised from ¥90 to ¥105 per share for 2025, lifting the payout ratio to 48.1%, and management plans a further increase to ¥110 per share in 2026, signaling continued commitment to shareholder returns. For the 2026 fiscal year, KH Neochem forecasts marginally lower full-year sales of ¥114.0 billion but expects operating income to rise 20.0% and net income to grow 11.5% to ¥8.7 billion, implying improved profitability and a more efficient earnings structure even in a flat or slightly weaker revenue environment.

The most recent analyst rating on (JP:4189) stock is a Hold with a Yen2798.00 price target. To see the full list of analyst forecasts on KH Neochem Co.,Ltd. stock, see the JP:4189 Stock Forecast page.

KH Neochem Cuts FY2025 Earnings Forecast on Weak Demand but Signals Profit Recovery in 2026
Jan 30, 2026

KH Neochem has cut its full-year consolidated forecast for the fiscal year ending December 31, 2025, trimming expected net sales from 127.4 billion yen to 115.0 billion yen and lowering projected operating income, ordinary income and net income by roughly 20–23% versus its previous outlook, bringing all major profit metrics below FY2024 levels. The downgrade reflects weak domestic demand and intensified competition from low-cost imports in basic chemicals, as well as a sharper-than-expected downturn in performance materials following a post-regulation demand recoil in the U.S. and a temporary slowdown in the air conditioner market linked to reduced impact from China’s appliance replacement subsidies, which has weighed on sales of refrigeration lubricant raw materials; nevertheless, the company is maintaining its dividend forecast for FY2025 and currently anticipates a recovery in FY2026 operating profit to around 13 billion yen, suggesting expectations of gradual operational improvement despite near-term headwinds.

The most recent analyst rating on (JP:4189) stock is a Hold with a Yen2772.00 price target. To see the full list of analyst forecasts on KH Neochem Co.,Ltd. stock, see the JP:4189 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 11, 2026